Two Sigma Investments, LP Neoleukin Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.68 - $0.91 $10,540 - $14,105	-15,500 Reduced 6.84%	211,194 $175,000
Q1 2023 May 15, 2023	SELL	$0.5 - $0.72 $36,171 - $52,086	-72,342 Reduced 24.19%	226,694 $158,000
Q4 2022 Feb 14, 2023	SELL	$0.4 - $0.55 $17,640 - $24,255	-44,100 Reduced 12.85%	299,036 $152,000
Q3 2022 Nov 14, 2022	BUY	$0.69 - $1.33 $21,157 - $40,781	30,663 Added 9.81%	343,136 $220,000
Q2 2022 Aug 15, 2022	BUY	$0.92 - $2.25 $63,022 - $154,131	68,503 Added 28.08%	312,473 $322,000
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $151,489 - $460,632	88,075 Added 56.5%	243,970 $459,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $165,925 - $276,543	35,683 Added 29.68%	155,895 $751,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $490,776 - $783,619	81,120 Added 207.51%	120,212 $869,000
Q2 2021 Aug 16, 2021	BUY	$9.23 - $13.12 $223,412 - $317,569	24,205 Added 162.59%	39,092 $361,000
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $1.73 Million - $2.43 Million	-153,850 Reduced 91.18%	14,887 $183,000
Q4 2020 Feb 16, 2021	BUY	$10.17 - $14.56 $227,858 - $326,216	22,405 Added 15.31%	168,737 $2.38 Million
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $543,319 - $954,737	56,128 Added 62.22%	146,332 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $512,693 - $878,535	51,527 Added 133.22%	90,204 $1.5 Million
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $152,883 - $340,740	24,981 Added 182.4%	38,677 $440,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $12.72 $139,567 - $669,924	-52,667 Reduced 79.36%	13,696 $169,000
Q3 2019 Nov 14, 2019	BUY	$2.33 - $3.76 $154,625 - $249,524	66,363 New	66,363 $189,000

Others Institutions Holding NLTX

# of Institutions

Shares Held

199K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

199K
Shares

$0
0.18% of portfolio

View Full List

About Neoleukin Therapeutics, Inc.

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

More about NLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account